Clinical trials: sponsored by Beijing Tongren Hospital
Hypersensitivity, Rhinitis
Evaluation Effects of Nasal Nitric Oxide Measurements Are Associated With Atopy Status in Chronic Nasal Inflammation
Nitric oxide (NO) was considered as a mediator of nasal inflammation and the measurement of nasal nitric oxide (nNO) may assist in the diagnosis of nasal inflammation.
- Conditions
- Hypersensitivity, Rhinitis, Respiratory Tract Diseases, Nasal Polyps
- Trial name
- NCT01295866
- Testing
- nasal nitric oxide
- Volunteers
- 131 people, healthy volunteers welcome
- Sponsor
- Beijing Tongren Hospital
Hypersensitivity, Psychologic Factors in Physical Conditions Classified Elsewhere
Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients
Allergic rhinitis (AR) and asthma are considered as "one airway, one disease". Although there is increasing evidence for an association between allergy and depression, it remains unknown if the relationship between AR and asthma…
- Conditions
- Hypersensitivity, Psychologic Factors in Physical Conditions Classified Elsewhere, Respiratory Tract Diseases, Allergic Rhinitis
- Trial name
- NCT01295255
- Volunteers
- 524 people
- Sponsor
- Beijing Tongren Hospital
Allergic Rhinitis, Effects of Immunotherapy
Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children
While allergen specific immunotherapy (SIT) is highly effective for allergic diseases in children, the underlying immunological mechanisms are unclear. Regulatory T (Treg) cells may be crucial in induction of tolerance.
- Trial name
- NCT01291381
- Testing
- Dermatophagoides pteronyssinus, Pharmacotherapy
- Where
- China
- Volunteers
- 50 people
- Sponsor
- Beijing Tongren Hospital
Pre-diabetes
Study TO Prevent Diabetes With Short-term Insulin Glargine Only
Pre-diabetes is a significant risk factor for the development of type 2 diabetes, as well as macrovascular and microvascular complication.
- Trial name
- STOP-GO (NCT01276912)
- Testing
- Insulin glargine, Lifestyle counseling
- Where
- China
- Volunteers
- 2,420 people
- Sponsor
- Beijing Tongren Hospital